FolioLanternBeta
EWEdwards Lifesciences

Donald Bobo Jr.

CVP,Strategy/Corp Development at Edwards Lifesciences, as of May 27, 2026Sold $11.2M of stock in the past 12 months: 42% under a disclosed plan and 58% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
152K
shares held after the latest filing, Edwards Lifesciences
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
133K
shares sold, past 12 months
8
days with sales
$2.0M
largest single day, Feb 25, 2026
1
company filed for

Share of stake sold at Edwards Lifesciences is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $951K under a disclosed planDec 2025: $954K no plan disclosedDecJan 2026: $971K under a disclosed planJanFeb 2026: $2.0M no plan disclosedFebMar 2026: $974K under a disclosed planMarApr 2026: $1.8M under a disclosed planAprMay 2026: $3.5M no plan disclosed$3.5MMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Edwards Lifesciences (EW)CVP,Strategy/Corp DevelopmentAug 7, 2008May 27, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.